Navigation Links
Abortion Pill approved by FDA,,

Mifepristone (known as RU-486 in Europe) has been around for over a decade and used by European women as an alternative to surgical abortion in early pregnancy. It has now been approved by FDA for sale in the USA. It will be avilable as Mifeprex.

Gloria Feldt, president of Planned Parenthood Inc said,"Mifepristone, or the early-abortion pill, is as significant a technological advance for women's health as the birth-control pill was 40 years ago, It will enable them, if they choose to terminate a pregnancy, to do that earlier (and) to do it without surgery. For many women, that is a very positive thing."

"The approval of mifepristone is the result of the FDA's careful evaluation of the scientific evidence related to the safe and effective use of this drug," said Dr. Jane Henney, commissioner of food and drugs. "The FDA's review and approval of this drug has adhered strictly to our legal mandate and mission as a science-based public health regulatory agency."
'"/>




Page: 1

Related medicine news :

1. Abortion made easy pill causes alarm in state
2. Treatment for fibroids with "Abortion Pill"
3. Abortion may cause mental illness
4. Abortion Does Not Increase Risk Of Depression In Women
5. Teenage Girls May Not Need Parents Consent For Abortion
6. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
7. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
8. Mother Claims Hefty Compensation For Failed Abortion Of Twins
9. Abortions does not increase risk of breast cancer
10. Bill to Ban Abortion In Indiana Introduced
11. Archbishop Slams Attempt to Legalize Abortion In Jamaica
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: